CME/CE Accredited Session
Sponsored by Industry
Click For Session
Session Times Listed in ET
Lee A. Lindquist, MD, MPH, MBA
COVID-19 has disproportionately impacted older adults through early high infection rates, social isolation, anxiety, depression and mortality. This session on polypharmacy and COVID-19 will improve how you treat the sequalae of COVID-19 in older adults and increase your awareness of polypharmacy. It will also provide the newest research on non-pharmacologic ways of treating the long-term effects of COVID-19 on older adults. Through interactive patient cases, Dr. Lee Lindquist will provide examples on how to safely and effectively manage the medications of your older adult patients during the COVID-19 pandemic.
Associate Professor of Medicine, Section Chief of Geriatrics, Northwestern University Feinberg School of Medicine, Chicago, IL
M. Susan Burke, MD, FACP | Rashmi B. Halker Singh, MD, FAHS, FAAN
Watch expert faculty discuss assess and treat migraine through the case of a young man with recurrent headaches. Treatment will focus on traditional and new preventive therapies for chronic migraine as well as patient self-management strategies to optimize management.
This session is designed to satisfy CME/CE requirements on Pain Management. Please check with your state licensing board for their specific requirements.
Clinical Associate Professor of Medicine, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Senior Advisor, Lankenau Medical Associates, Lankenau Medical Center, Wynnewood, PA
Headache Fellowship Program Director, Associate Professor of Neurology, Mayo Clinic, Scottsdale, AZ
Supported by TEVA
Is It Time to Reconsider Your Treatment Strategy in Your Patients With T2D?
Carlos Campos, MD, MPH, CDE
Explore efficacy and safety data for 2 GLP-1 RA options for adults with T2D. A data review from pivotal glycemic control trials as well as cardiovascular outcomes data will be presented.
Clinical Adjunct Professor, Department of Family Medicine, UT Health San Antonio, San Antonio, TX
Sponsored by Novo Nordisk
Acute Exacerbations: Predictors of Poor Outcomes in COPD
Jill Ohar, MD
This program will examine the risk factors associated with COPD exacerbations and the potential impacts of acute exacerbations on patient health, quality of life, and mortality. An understanding of COPD exacerbations and the range of consequences highlights opportunities to optimize COPD management earlier in the course of disease.
Professor, Pulmonary, Critical Care, Allergy, and Immunologic Medicine, Wake Forest University
Sponsored by AstraZeneca
Managing Influenza: Practical Strategies For Primary Care
Pamela Kushner, MD, FAAFP | Paul E. Sax, MD
Is influenza going viral in your practice? This session on influenza diagnosis and management will improve how you respond when annual fluctuations in vaccine efficacy expose your patients to risk of serious illness. Through interactive patient cases, the faculty will demonstrate how to identify and treat patients with suspected influenza, including patients at high risk for complications. These practical, evidence-based strategies will help you to use antiviral medications effectively and reduce the burden of influenza.
Clinical Professor, University of California Irvine Medical Center; Director, Kushner Wellness Center, Los Alamitos, CA
Clinical Director, Division of Infectious Diseases, Brigham and Women's Hospital; Professor of Medicine, Harvard Medical School, Boston, MA
Supported by Genentech
Neil Skolnik, M.D.
Short-acting B2-agonists (SABA) have been the mainstay of rescue therapy in asthma, regardless of disease severity. However, we must ask ourselves: at what point does SABA use indicate poor asthma control, and can we do more to prevent exacerbations and oral corticosteroid exposure? This program will examine the relationship between SABA reliance, disease control, and patient behavior and review real world evidence updates to highlight a window of opportunity to prevent exacerbations.
Professor of Family and Community Medicine Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health
Sponsored by AstraZeneca